Literature DB >> 31537693

CRISPR/Cas9-mediated gene deletion efficiently retards the progression of Philadelphia-positive acute lymphoblastic leukemia in a p210 BCR-ABL1T315I mutation mouse model.

Yu-Ting Tan1,2, Lin Ye2, Fei Xie2,3, Jiaming Wang2, Markus Müschen4,5, Sai-Juan Chen6, Yuet Wai Kan2,4,7, Han Liu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31537693      PMCID： PMC7193494          DOI： 10.3324/haematol.2019.229013

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

Review 1.  BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia.

Authors:  Stephanie Salesse; Catherine M Verfaillie
Journal:  Oncogene       Date:  2002-12-09       Impact factor: 9.867

2.  A rapid and general assay for monitoring endogenous gene modification.

Authors:  Dmitry Y Guschin; Adam J Waite; George E Katibah; Jeffrey C Miller; Michael C Holmes; Edward J Rebar
Journal:  Methods Mol Biol       Date:  2010

3.  A common signaling cascade may underlie "addiction" to the Src, BCR-ABL, and EGF receptor oncogenes.

Authors:  Sreenath V Sharma; Patrycja Gajowniczek; Inna P Way; Diana Y Lee; Jane Jiang; Yuki Yuza; Marie Classon; Daniel A Haber; Jeffrey Settleman
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

4.  Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia.

Authors:  Seyedmehdi Shojaee; Rebecca Caeser; Maike Buchner; Eugene Park; Srividya Swaminathan; Christian Hurtz; Huimin Geng; Lai N Chan; Lars Klemm; Wolf-Karsten Hofmann; Yi Hua Qiu; Nianxiang Zhang; Kevin R Coombes; Elisabeth Paietta; Jeffery Molkentin; H Phillip Koeffler; Cheryl L Willman; Stephen P Hunger; Ari Melnick; Steven M Kornblau; Markus Müschen
Journal:  Cancer Cell       Date:  2015-06-11       Impact factor: 31.743

5.  Characterization of genomic deletion efficiency mediated by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells.

Authors:  Matthew C Canver; Daniel E Bauer; Abhishek Dass; Yvette Y Yien; Jacky Chung; Takeshi Masuda; Takahiro Maeda; Barry H Paw; Stuart H Orkin
Journal:  J Biol Chem       Date:  2014-06-06       Impact factor: 5.157

6.  Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial.

Authors:  Jorge E Cortes; Dong-Wook Kim; Javier Pinilla-Ibarz; Philipp D le Coutre; Ronald Paquette; Charles Chuah; Franck E Nicolini; Jane F Apperley; H Jean Khoury; Moshe Talpaz; Daniel J DeAngelo; Elisabetta Abruzzese; Delphine Rea; Michele Baccarani; Martin C Müller; Carlo Gambacorti-Passerini; Stephanie Lustgarten; Victor M Rivera; Frank G Haluska; François Guilhot; Michael W Deininger; Andreas Hochhaus; Timothy P Hughes; Neil P Shah; Hagop M Kantarjian
Journal:  Blood       Date:  2018-03-22       Impact factor: 22.113

Review 7.  Management of adult Ph-positive acute lymphoblastic leukemia.

Authors:  Sabina Chiaretti; Robin Foà
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015

Review 8.  Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors.

Authors:  Ami B Patel; Thomas O'Hare; Michael W Deininger
Journal:  Hematol Oncol Clin North Am       Date:  2017-08       Impact factor: 3.722

9.  Detection and Quantification of HDR and NHEJ Induced by Genome Editing at Endogenous Gene Loci Using Droplet Digital PCR.

Authors:  Yuichiro Miyaoka; Steven J Mayerl; Amanda H Chan; Bruce R Conklin
Journal:  Methods Mol Biol       Date:  2018

10.  In vivo genome editing using Staphylococcus aureus Cas9.

Authors:  F Ann Ran; Le Cong; Winston X Yan; David A Scott; Jonathan S Gootenberg; Andrea J Kriz; Bernd Zetsche; Ophir Shalem; Xuebing Wu; Kira S Makarova; Eugene V Koonin; Phillip A Sharp; Feng Zhang
Journal:  Nature       Date:  2015-04-01       Impact factor: 49.962
View more
  2 in total

1.  Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity.

Authors:  Eric Alves; Emily McLeish; Pilar Blancafort; Jerome D Coudert; Silvana Gaudieri
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

Review 2.  Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and Clinical Implications.

Authors:  Maheswaran Solayappan; Adam Azlan; Kang Zi Khor; Mot Yee Yik; Matiullah Khan; Narazah Mohd Yusoff; Emmanuel Jairaj Moses
Journal:  Front Genet       Date:  2022-01-28       Impact factor: 4.599
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.